Ironwood Pharmaceuticals - M&A Summary and Business Overview

Life ScienceCompany

Ironwood Pharmaceuticals M&A Summary

Ironwood Pharmaceuticals has acquired 1 company, including 1 in the last 5 years.

Ironwood Pharmaceuticals’ largest acquisition to date was in 2023, when it acquired VectivBio AG for $1.0B. The Company’s most targeted sectors include life science (100%).

Ironwood Pharmaceuticals Business Overview

Where is Ironwood Pharmaceuticals headquartered?

Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts.

What is Ironwood Pharmaceuticals’ revenue?

Ironwood Pharmaceuticals disclosed revenue of 443M USD for 2023 and 411M USD for 2022.

How many employees does Ironwood Pharmaceuticals have?

Ironwood Pharmaceuticals has 267 employees.

What sector is Ironwood Pharmaceuticals in?

Ironwood Pharmaceuticals is a life science company.

When was Ironwood Pharmaceuticals founded?

Ironwood Pharmaceuticals was founded in 1998.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 5

Ironwood Pharmaceuticals

Ironwood Pharmaceuticals, Inc.

100 Summer Street, Suite 2300,
Boston, Massachusetts 02110
United States,
(617) 621-7722
www.ironwoodpharma.com

Ironwood Pharmaceuticals is a healthcare company, that focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. Ironwood Pharmaceuticals was founded in 1998 and is based in Boston, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # - - - - 1 - 1
vol $1.0B $1.0B
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
VectivBio AG 2023-05-22 1.0B USD Add-on Acquisition
Basel, Switzerland · www.vectivbio.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 1.0B (100%) - -
Total 1 $1.0B - -

By Geo

State/Country Buy Value Sell Value
Switzerland 1 1.0B - -
Total 1 $1.0B - -

Top M&A Advisors

Financial Deals
J.P. Morgan Securities
1
RBC Capital Markets
1
Citigroup Investment Banking
1
Legal Deals
Advestra AG
1
Latham & Watkins
1

Deal Values

buy # Total
> $1B 1 $1.0B
TOTAL $1.0B
Largest VectivBio AG
$1.0B (2023-05-22)

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.